Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Evercore ISI HealthCONx Conference Transcript

Nov 29, 2023 / 02:10PM GMT
Release Date Price: $197.1 (+0.96%)
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst

Awesome. All right. So let's get started. Hi, everybody. I am Elizabeth Anderson. I'm the health care technology and distribution analyst here at Evercore. I'm very pleased to be joined by Jim Foster, who I'm sure many of you know and CEO of Charles River and Todd Spencer, who does IR. Thank you very much for joining us today. Happy to have you.

Questions & Answers

Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst

Maybe just to start off, I know hot topic, as always, is sort of the current demand environment across many different businesses and tools and other -- in the clinical side of CROs. Maybe just talking through a couple of the different points in your business. How do you sort of think about sort of the lay of the land in terms of RMS. We've heard about some of the comments on China, but maybe sort of differentiate between sort of the environment in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot